Pegasys® pre-filled syringes (pegylated interferon alfa-2a): Risk of possible shortages
2012.10.04
Active substance: pegylated interferon alfa-2a
A further information letter states that the risk of possible shortages of Pegasys® pre-filled syringes will persist over longer period of time than originally expected. The company Roche now estimates that the supply situation of the pre-filled syringes will be normalised by the end of June 2013 and not, as communicated up to now, by September of 2012.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN